198 related articles for article (PubMed ID: 28621164)
1. Effect of psoriasis activity and topical treatment on plasma epidermal growth factor (EGF) and its soluble receptor (sEGFR).
Szterling-Jaworowska M; Baran A; Myśliwiec H; Flisiak I
J Dermatolog Treat; 2018 Mar; 29(2):135-139. PubMed ID: 28621164
[TBL] [Abstract][Full Text] [Related]
2. Effect of psoriasis activity on epidermal growth factor (EGF) and the concentration of soluble EGF receptor in serum and plaque scales.
Flisiak I; Szterling-Jaworowska M; Baran A; Rogalska-Taranta M
Clin Exp Dermatol; 2014 Jun; 39(4):461-7. PubMed ID: 24825137
[TBL] [Abstract][Full Text] [Related]
3. Concentration of an epidermal growth factor in blood serum of males during topical treatment of psoriasis.
Pietrzak A; Miturski R; Krasowska D; Postawski K; Lecewicz-Toruń B
J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):1-5. PubMed ID: 10188141
[TBL] [Abstract][Full Text] [Related]
4. Alteration of the serum levels of the epidermal growth factor receptor and its ligands in patients with non-small cell lung cancer and head and neck carcinoma.
Lemos-González Y; Rodríguez-Berrocal FJ; Cordero OJ; Gómez C; Páez de la Cadena M
Br J Cancer; 2007 May; 96(10):1569-78. PubMed ID: 17453000
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the prognostic value of soluble epidermal growth factor receptor plasma concentration in advanced non-small-cell lung cancer patients.
Jantus-Lewintre E; Sirera R; Cabrera A; Blasco A; Caballero C; Iranzo V; Rosell R; Camps C
Clin Lung Cancer; 2011 Sep; 12(5):320-7. PubMed ID: 21729651
[TBL] [Abstract][Full Text] [Related]
6. The effect of topical treatment and psoriasis severity on serum retinol-binding protein-4 levels.
Baran A; Swiderska M; Flisiak I
J Dermatolog Treat; 2016; 27(2):114-9. PubMed ID: 26293108
[TBL] [Abstract][Full Text] [Related]
7. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
[TBL] [Abstract][Full Text] [Related]
8. Effect of psoriasis treatment on plasma concentrations of metalloproteinase-1 and tissue inhibitor of metalloproteinases-1.
Flisiak I; Myśliwiec H; Chodynicka B
J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):418-21. PubMed ID: 15987285
[TBL] [Abstract][Full Text] [Related]
9. Effect of psoriasis activity and topical treatment on serum lipocalin-2 levels.
Baran A; Świderska M; Myśliwiec H; Flisiak I
J Dermatolog Treat; 2017 Mar; 28(2):136-140. PubMed ID: 27165470
[TBL] [Abstract][Full Text] [Related]
10. Dithranol treatment of plaque-type psoriasis increases serum TNF-like weak inducer of apoptosis (TWEAK).
Myśliwiec H; Myśliwiec P; Baran A; Flisiak I
Adv Med Sci; 2016 Sep; 61(2):207-211. PubMed ID: 26895458
[TBL] [Abstract][Full Text] [Related]
11. Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.
Baron AT; Cora EM; Lafky JM; Boardman CH; Buenafe MC; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):103-13. PubMed ID: 12582019
[TBL] [Abstract][Full Text] [Related]
12. Preliminary Evidence on the Diagnostic and Molecular Role of Circulating Soluble EGFR in Non-Small Cell Lung Cancer.
Lococo F; Paci M; Rapicetta C; Rossi T; Sancisi V; Braglia L; Cavuto S; Bisagni A; Bongarzone I; Noonan DM; Albini A; Maramotti S
Int J Mol Sci; 2015 Aug; 16(8):19612-30. PubMed ID: 26295387
[TBL] [Abstract][Full Text] [Related]
13. [Impact of serum epidermal growth factor on progressive psoriasis vulgaris and regulation of Chinese herbal medicine for cleaving heat, cooling blood, and detoxicating on it].
Ma LL; Chen PF; Luo F
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Aug; 28(8):733-5. PubMed ID: 18928101
[TBL] [Abstract][Full Text] [Related]
14. Plasma transforming growth factor beta1 as a biomarker of psoriasis activity and treatment efficacy.
Flisiak I; Porebski P; Flisiak R; Chodynicka B
Biomarkers; 2003; 8(5):437-43. PubMed ID: 14602527
[TBL] [Abstract][Full Text] [Related]
15. Explorative immunohistochemical study to evaluate the addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis.
Bovenschen HJ; Gerritsen WJ; van Rens DW; Seyger MM; de Jong EM; van de Kerkhof PC
Arch Dermatol Res; 2007 Feb; 298(9):457-63. PubMed ID: 17136563
[TBL] [Abstract][Full Text] [Related]
16. Alteration and significance of heparin-binding epidermal-growth-factor-like growth factor in psoriatic epidermis.
Zheng Y; Peng Z; Wang Y; Tan S; Xi Y; Wang G
Dermatology; 2003; 207(1):22-7. PubMed ID: 12835543
[TBL] [Abstract][Full Text] [Related]
17. Epidermal barrier and oxidative stress parameters improve during in 311 nm narrow band UVB phototherapy of plaque type psoriasis.
Darlenski R; Hristakieva E; Aydin U; Gancheva D; Gancheva T; Zheleva A; Gadjeva V; Fluhr JW
J Dermatol Sci; 2018 Jul; 91(1):28-34. PubMed ID: 29610017
[TBL] [Abstract][Full Text] [Related]
18. Serum YKL-40 as a potential biomarker of inflammation in psoriasis.
Baran A; Myśliwiec H; Szterling-Jaworowska M; Kiluk P; Świderska M; Flisiak I
J Dermatolog Treat; 2018 Feb; 29(1):19-23. PubMed ID: 28498006
[TBL] [Abstract][Full Text] [Related]
19. Ligand-binding enhances the affinity of dimerization of the extracellular domain of the epidermal growth factor receptor.
Odaka M; Kohda D; Lax I; Schlessinger J; Inagaki F
J Biochem; 1997 Jul; 122(1):116-21. PubMed ID: 9276679
[TBL] [Abstract][Full Text] [Related]
20. Dimethylfumarate for psoriasis: Pronounced effects on lesional T-cell subsets, epidermal proliferation and differentiation, but not on natural killer T cells in immunohistochemical study.
Bovenschen HJ; Langewouters AM; van de Kerkhof PC
Am J Clin Dermatol; 2010; 11(5):343-50. PubMed ID: 20553063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
